Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Novo Nordisk to discontinue Levemir insulin in U.S. market
Reuters
Wed, 11/8/23 - 09:59 pm
Novo Nordisk
Levemir
insulin
diabetes
An obesity drug biotech gets buy-in from Eli Lilly, venture firms
BioPharma Dive
Tue, 11/7/23 - 09:50 am
OrsoBio
Eli Lilly
funding
obesity
diabetes
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Motley Fool
Wed, 10/25/23 - 09:51 am
Novo Nordisk
Ozempic
Wegovy
diabetes
weight loss
Belgium plans temporary ban on use of Ozempic for weight loss
Yahoo/Reuters
Tue, 10/24/23 - 09:39 am
Novo Nordisk
Ozempic
diabetes
weight loss
Belgium
drug shortages
Insulet Omnipod 5 iPhone App FDA Cleared
Medical Devices and Diagnostics Industry
Mon, 10/23/23 - 05:09 pm
Medtech
Insulet
Omnipod 5
FDA
insulin delivery
diabetes
Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral
Yahoo/Reuters
Thu, 10/12/23 - 05:24 pm
Fresenius Medical Care
Ozempic
diabetes
weight loss
Novo Nordisk
dialysis
Medtech
Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals
BioSpace
Wed, 10/11/23 - 10:15 am
Novo Nordisk
semaglutide
clinical trials
diabetes
chronic kidney disease
Abbott’s Biowearable Performs Well In U.K. Ahead Of U.S. Launch
Forbes
Tue, 10/10/23 - 11:55 pm
Abbott Labs
biowearables
UK
diabetes
Lingo
devices
Medtech
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
Motley Fool
Fri, 10/6/23 - 10:08 am
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
diabetes
weight loss
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Thu, 10/5/23 - 10:21 am
Viatris
generics
Novo Nordisk
Ozempic
Wegovy
diabetes
patents
USPTO
Lilly names new diabetes and obesity chief as Mounjaro sales take off
BioPharma Dive
Wed, 10/4/23 - 11:23 pm
Eli Lilly
Mounjaro
diabetes
FDA Adds New Warning for Ileus to Ozempic Label
HCP Live
Thu, 09/28/23 - 11:55 am
Novo Nordisk
Ozempic
diabetes
weight losss
FDA
ileus
labeling
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Fast Company
Fri, 09/22/23 - 12:03 pm
Novo Nordisk
Ozempic
logo
branding
diabetes
weight loss
FDA panel votes against diabetes implant due to safety concerns
Reuters
Fri, 09/22/23 - 11:48 am
Intarcia
diabetes
FDA
ITCA 650
Medtech
Intarcia, a failed diabetes "unicorn," could be resurrected
Axios
Wed, 09/20/23 - 11:17 pm
Intarcia
FDA
diabetes
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
CNBC
Tue, 09/19/23 - 10:26 pm
Eli Lilly
legal
Mounjaro
diabetes
Novo Nordisk taps Aspen to help produce insulin for Africa
Fierce Pharma
Tue, 09/19/23 - 10:49 am
Novo Nordisk
diabetes
Africa
insulin
Aspen Pharmacare
drug manufacturing
How Payers Are Reacting to Insulin Price Changes
Drug Channels
Fri, 09/15/23 - 11:37 am
payers
insurance
insulin
diabetes
drug pricing
Inflation Reduction Act
Medicare
NICE changes its mind on Lilly's Mounjaro for diabetes
Pharmaphorum
Fri, 09/8/23 - 10:09 am
Eli Lilly
Mounjaro
diabetes
NHS
UK
Novo Nordisk Is Already Working on Ozempic 2.0
Motley Fool
Thu, 09/7/23 - 10:12 am
Novo Nordisk
diabetes
obesity
weight loss
Ozempic
Wegovy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »